Physiologically Based Pharmacokinetic Models for Infliximab, Ipilimumab, and Nivolumab Developed with GastroPlus to Predict Hepatic Concentrations is a research paper published in Pharmaceutics (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R44TR003535
National Institutes of Health
Grant: 2R44TR003535-03
Software for predicting liver injury from biologics drug candidates using data from a human liver microphysiology system
FWCI
0.81
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals